<DOC>
	<DOCNO>NCT00801437</DOCNO>
	<brief_summary>This study design evaluate safety tolerability Xalacom patient primary glaucoma</brief_summary>
	<brief_title>Non Interventional Study With Primary Open Angle Glaucoma and/or Ocular Hypertension Patients Treated With XalacomÂ® After Failure Previous Antiglaucoma Therapy .</brief_title>
	<detailed_description>accord physician decision , patient meet inclusion exclusion criterion sign ICD</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Glaucoma , Open-Angle</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Timolol</mesh_term>
	<criteria>primary open angle glaucoma ocular hypertension age &gt; 18 year bradycardia obstructive pulmonary disease hypersensitivity drug</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>glaucoma , open-angle , non-interventional study , safety , tolerability</keyword>
</DOC>